REIT - Residential
Compare Stocks
5 / 10Stock Comparison
IRT vs NMR vs MS vs GS vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
Banks - Diversified
IRT vs NMR vs MS vs GS vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Residential | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets | Banks - Diversified |
| Market Cap | $3.86B | $22.85B | $302.59B | $287.62B | $825.89B |
| Revenue (TTM) | $662M | $4.76T | $103.14B | $126.85B | $270.79B |
| Net Income (TTM) | $48M | $370.05B | $16.18B | $16.67B | $58.03B |
| Gross Margin | 20.2% | 45.6% | 55.6% | 41.1% | 58.6% |
| Operating Margin | 17.5% | 11.3% | 17.1% | 14.5% | 27.7% |
| Forward P/E | 99.9x | 9.7x | 16.0x | 15.6x | 13.8x |
| Total Debt | $2.28B | $17.30T | $360.49B | $616.93B | $751.15B |
| Cash & Equiv. | $48M | $4.30T | $75.74B | $182.09B | $469.32B |
IRT vs NMR vs MS vs GS vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Independence Realty… (IRT) | 100 | 165.5 | +65.5% |
| Nomura Holdings, In… (NMR) | 100 | 185.8 | +85.8% |
| Morgan Stanley (MS) | 100 | 430.3 | +330.3% |
| The Goldman Sachs G… (GS) | 100 | 471.2 | +371.2% |
| JPMorgan Chase & Co. (JPM) | 100 | 314.8 | +214.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IRT vs NMR vs MS vs GS vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IRT is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 4 yrs, beta 0.48, yield 4.0%
- Lower volatility, beta 0.48, Low D/E 63.6%, current ratio 0.05x
- Beta 0.48 vs GS's 1.47, lower leverage
NMR has the current edge in this matchup, primarily because of its strength in valuation efficiency and defensive.
- PEG 0.49 vs MS's 1.80
- Beta 1.32, yield 4.8%, current ratio 1.43x
- Lower P/E (9.7x vs 13.8x), PEG 0.49 vs 1.06
- 4.8% yield, 3-year raise streak, vs JPM's 1.7%
MS is the clearest fit if your priority is long-term compounding.
- 7.3% 10Y total return vs GS's 5.3%
GS is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 17.0%, EPS growth 77.3%
- 17.0% NII/revenue growth vs IRT's 2.8%
- +70.6% vs IRT's -11.9%
JPM ranks third and is worth considering specifically for bank quality.
- NIM 2.3% vs GS's 0.5%
- 21.6% margin vs IRT's 7.3%
- 1.3% ROA vs NMR's 0.6%, ROIC 5.4% vs 1.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 17.0% NII/revenue growth vs IRT's 2.8% | |
| Value | Lower P/E (9.7x vs 13.8x), PEG 0.49 vs 1.06 | |
| Quality / Margins | 21.6% margin vs IRT's 7.3% | |
| Stability / Safety | Beta 0.48 vs GS's 1.47, lower leverage | |
| Dividends | 4.8% yield, 3-year raise streak, vs JPM's 1.7% | |
| Momentum (1Y) | +70.6% vs IRT's -11.9% | |
| Efficiency (ROA) | 1.3% ROA vs NMR's 0.6%, ROIC 5.4% vs 1.4% |
IRT vs NMR vs MS vs GS vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IRT vs NMR vs MS vs GS vs JPM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 1 of 6 categories
NMR leads 1 • IRT leads 1 • GS leads 1 • MS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NMR is the larger business by revenue, generating $4.76T annually — 7190.5x IRT's $662M. JPM is the more profitable business, keeping 21.6% of every revenue dollar as net income compared to IRT's 7.3%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $662M | $4.76T | $103.1B | $126.9B | $270.8B |
| EBITDAEarnings before interest/tax | $365M | $533.0B | $26.3B | $23.4B | $81.3B |
| Net IncomeAfter-tax profit | $48M | $370.1B | $16.2B | $16.7B | $58.0B |
| Free Cash FlowCash after capex | $139M | $0 | -$6.7B | $15.8B | -$119.7B |
| Gross MarginGross profit ÷ Revenue | +20.2% | +45.6% | +55.6% | +41.1% | +58.6% |
| Operating MarginEBIT ÷ Revenue | +17.5% | +11.3% | +17.1% | +14.5% | +27.7% |
| Net MarginNet income ÷ Revenue | +7.3% | +7.6% | +13.0% | +11.3% | +21.6% |
| FCF MarginFCF ÷ Revenue | +21.1% | -25.2% | -2.0% | -12.1% | -15.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -101.4% | -5.5% | +48.9% | +45.8% | +16.0% |
Valuation Metrics
NMR leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 10.4x trailing earnings, NMR trades at a 85% valuation discount to IRT's 68.2x P/E. Adjusting for growth (PEG ratio), NMR offers better value at 0.53x vs MS's 2.69x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.9B | $22.9B | $302.6B | $287.6B | $825.9B |
| Enterprise ValueMkt cap + debt − cash | $6.1B | $106.0B | $587.3B | $722.5B | $1.11T |
| Trailing P/EPrice ÷ TTM EPS | 68.21x | 10.40x | 23.92x | 22.84x | 15.51x |
| Forward P/EPrice ÷ next-FY EPS est. | 99.88x | 9.69x | 16.01x | 15.64x | 13.79x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.53x | 2.69x | 1.63x | 1.19x |
| EV / EBITDAEnterprise value multiple | 16.71x | 27.25x | 25.81x | 34.75x | 13.34x |
| Price / SalesMarket cap ÷ Revenue | 5.87x | 0.75x | 2.93x | 2.27x | 3.05x |
| Price / BookPrice ÷ Book value/share | 1.07x | 0.98x | 2.91x | 2.53x | 2.56x |
| Price / FCFMarket cap ÷ FCF | 26.33x | — | — | — | — |
Profitability & Efficiency
IRT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 16.1% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $1 for IRT. IRT carries lower financial leverage with a 0.64x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), IRT scores 6/9 vs GS's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.3% | +10.2% | +14.6% | +12.6% | +16.1% |
| ROA (TTM)Return on assets | +0.8% | +0.6% | +1.2% | +0.9% | +1.3% |
| ROICReturn on invested capital | +1.6% | +1.4% | +2.9% | +1.9% | +5.4% |
| ROCEReturn on capital employed | +2.4% | +2.4% | +3.8% | +3.6% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.64x | 4.49x | 3.42x | 5.06x | 2.18x |
| Net DebtTotal debt minus cash | $2.2B | $13.00T | $284.7B | $434.8B | $281.8B |
| Cash & Equiv.Liquid assets | $48M | $4.30T | $75.7B | $182.1B | $469.3B |
| Total DebtShort + long-term debt | $2.3B | $17.30T | $360.5B | $616.9B | $751.1B |
| Interest CoverageEBIT ÷ Interest expense | 1.73x | 0.20x | 0.44x | 0.31x | 0.74x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $26,440 today (with dividends reinvested), compared to $11,775 for IRT. Over the past 12 months, GS leads with a +70.6% total return vs IRT's -11.9%. The 3-year compound annual growth rate (CAGR) favors GS at 43.5% vs IRT's 2.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.0% | -6.3% | +5.7% | +1.8% | -5.0% |
| 1-Year ReturnPast 12 months | -11.9% | +47.1% | +63.0% | +70.6% | +25.2% |
| 3-Year ReturnCumulative with dividends | +7.4% | +145.2% | +138.4% | +195.2% | +134.6% |
| 5-Year ReturnCumulative with dividends | +17.8% | +68.5% | +136.2% | +164.4% | +104.3% |
| 10-Year ReturnCumulative with dividends | +191.8% | +141.5% | +732.3% | +534.3% | +461.3% |
| CAGR (3Y)Annualised 3-year return | +2.4% | +34.8% | +33.6% | +43.5% | +32.9% |
Risk & Volatility
Evenly matched — IRT and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
IRT is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than GS's 1.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 97.6% from its 52-week high vs NMR's 82.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 1.32x | 1.37x | 1.47x | 1.00x |
| 52-Week HighHighest price in past year | $19.61 | $9.58 | $194.83 | $984.70 | $337.25 |
| 52-Week LowLowest price in past year | $14.60 | $5.48 | $118.20 | $547.74 | $248.83 |
| % of 52W HighCurrent price vs 52-week peak | +83.5% | +82.6% | +97.6% | +94.0% | +90.8% |
| RSI (14)Momentum oscillator 0–100 | 62.4 | 51.7 | 66.0 | 59.5 | 59.4 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 2.1M | 5.4M | 2.0M | 8.3M |
Analyst Outlook
Evenly matched — NMR and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IRT as "Buy", NMR as "Hold", MS as "Buy", GS as "Hold", JPM as "Buy". Consensus price targets imply 22.7% upside for IRT (target: $20) vs -26.8% for NMR (target: $6). For income investors, NMR offers the higher dividend yield at 4.77% vs GS's 1.46%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $20.08 | $5.79 | $205.75 | $995.89 | $338.78 |
| # AnalystsCovering analysts | 27 | 9 | 52 | 55 | 61 |
| Dividend YieldAnnual dividend ÷ price | +4.0% | +4.8% | +2.0% | +1.5% | +1.7% |
| Dividend StreakConsecutive years of raises | 4 | 3 | 11 | 12 | 14 |
| Dividend / ShareAnnual DPS | $0.66 | $59.06 | $3.81 | $13.48 | $5.13 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.8% | +2.8% | +1.4% | +3.5% | +3.5% |
JPM leads in 1 of 6 categories (Income & Cash Flow). NMR leads in 1 (Valuation Metrics). 2 tied.
IRT vs NMR vs MS vs GS vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IRT or NMR or MS or GS or JPM a better buy right now?
For growth investors, The Goldman Sachs Group, Inc.
(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus 2. 8% for Independence Realty Trust, Inc. (IRT). Nomura Holdings, Inc. (NMR) offers the better valuation at 10. 4x trailing P/E (9. 7x forward), making it the more compelling value choice. Analysts rate Independence Realty Trust, Inc. (IRT) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IRT or NMR or MS or GS or JPM?
On trailing P/E, Nomura Holdings, Inc.
(NMR) is the cheapest at 10. 4x versus Independence Realty Trust, Inc. at 68. 2x. On forward P/E, Nomura Holdings, Inc. is actually cheaper at 9. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Nomura Holdings, Inc. wins at 0. 49x versus Morgan Stanley's 1. 80x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — IRT or NMR or MS or GS or JPM?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +164. 4%, compared to +17. 8% for Independence Realty Trust, Inc. (IRT). Over 10 years, the gap is even starker: MS returned +732. 3% versus NMR's +141. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IRT or NMR or MS or GS or JPM?
By beta (market sensitivity over 5 years), Independence Realty Trust, Inc.
(IRT) is the lower-risk stock at 0. 48β versus The Goldman Sachs Group, Inc. 's 1. 47β — meaning GS is approximately 204% more volatile than IRT relative to the S&P 500. On balance sheet safety, Independence Realty Trust, Inc. (IRT) carries a lower debt/equity ratio of 64% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IRT or NMR or MS or GS or JPM?
By revenue growth (latest reported year), The Goldman Sachs Group, Inc.
(GS) is pulling ahead at 17. 0% versus 2. 8% for Independence Realty Trust, Inc. (IRT). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to 7. 2% for Nomura Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IRT or NMR or MS or GS or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 21. 6% net margin versus 7. 6% for Nomura Holdings, Inc. — meaning it keeps 21. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 27. 7% versus 11. 3% for NMR. At the gross margin level — before operating expenses — JPM leads at 58. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IRT or NMR or MS or GS or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Nomura Holdings, Inc. (NMR) is the more undervalued stock at a PEG of 0. 49x versus Morgan Stanley's 1. 80x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Nomura Holdings, Inc. (NMR) trades at 9. 7x forward P/E versus 99. 9x for Independence Realty Trust, Inc. — 90. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IRT: 22. 7% to $20. 08.
08Which pays a better dividend — IRT or NMR or MS or GS or JPM?
All stocks in this comparison pay dividends.
Nomura Holdings, Inc. (NMR) offers the highest yield at 4. 8%, versus 1. 5% for The Goldman Sachs Group, Inc. (GS).
09Is IRT or NMR or MS or GS or JPM better for a retirement portfolio?
For long-horizon retirement investors, Independence Realty Trust, Inc.
(IRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 4. 0% yield, +191. 8% 10Y return). Both have compounded well over 10 years (IRT: +191. 8%, NMR: +141. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IRT and NMR and MS and GS and JPM?
These companies operate in different sectors (IRT (Real Estate) and NMR (Financial Services) and MS (Financial Services) and GS (Financial Services) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IRT is a small-cap income-oriented stock; NMR is a mid-cap deep-value stock; MS is a large-cap high-growth stock; GS is a large-cap high-growth stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.